1. Home
  2. MSGM vs IMNN Comparison

MSGM vs IMNN Comparison

Compare MSGM & IMNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Motorsport Games Inc.

MSGM

Motorsport Games Inc.

HOLD

Current Price

$3.07

Market Cap

13.4M

Sector

Technology

ML Signal

HOLD

Logo Imunon Inc.

IMNN

Imunon Inc.

HOLD

Current Price

$3.99

Market Cap

12.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MSGM
IMNN
Founded
2018
1982
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
13.4M
12.9M
IPO Year
2021
1985

Fundamental Metrics

Financial Performance
Metric
MSGM
IMNN
Price
$3.07
$3.99
Analyst Decision
Buy
Analyst Count
0
2
Target Price
N/A
$182.61
AVG Volume (30 Days)
68.4K
75.0K
Earning Date
11-06-2025
02-26-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.81
N/A
Revenue
$9,424,138.00
N/A
Revenue This Year
$69.07
N/A
Revenue Next Year
$30.56
N/A
P/E Ratio
$3.82
N/A
Revenue Growth
11.38
N/A
52 Week Low
$0.73
$2.99
52 Week High
$5.41
$41.22

Technical Indicators

Market Signals
Indicator
MSGM
IMNN
Relative Strength Index (RSI) 53.42 50.15
Support Level $2.93 $2.99
Resistance Level $3.25 $4.20
Average True Range (ATR) 0.20 0.33
MACD -0.01 0.05
Stochastic Oscillator 42.42 72.73

Price Performance

Historical Comparison
MSGM
IMNN

About MSGM Motorsport Games Inc.

Motorsport Games Inc is a motorsport network company that combines engaging video games with esports competitions and content for racing fans and gamers around the globe. The company has its reportable segments into the development and publishing of interactive racing video games, entertainment content and services, and the organization and facilitation of esports tournaments, competitions, and events for licensed racing games as well as on behalf of third-party video game racing series and other video game publishers. The majority of the revenue is earned from Gaming.

About IMNN Imunon Inc.

Imunon Inc is a clinical-stage biotechnology company focused on advancing a portfolio of treatments that harness the body's natural mechanisms to generate safe, effective, and durable responses across various human diseases, constituting a differentiating approach from conventional therapies. It is developing its non-viral DNA technology across its modalities. Its clinical program, IMNN-001, is a DNA-based immunotherapy for the localized treatment of ovarian cancer that has completed Phase II clinical studies. Additionally, the Company has entered a first-in-human study of its COVID-19 booster vaccine (IMNN-101).

Share on Social Networks: